UPDATE 3-Alexion bets on Portola's bleeding antidote with $1.41 bln deal
May 05, 2020 at 10:55 AM EDT
Alexion Pharmaceuticals Inc on Tuesday agreed to buy Portola Pharmaceuticals Inc in a $1.41 billion deal, as it looks to exploit smaller rival's blood-thinning antidote which has reached only a tiny portion of its target population.
